Related Experiment Video
Updated: Jul 30, 2026

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species
Published on: February 27, 2018
Pathological mechanisms in Huntington's disease and other polyglutamine expansion diseases
A Lunkes1, Y Trottier, J L Mandel
1Institut de Génétique et Biologie Moléculaire et Cellulaire, INSERM/CNRS/Université Louis Pasteur, Illkirch, France.
Insights
Huntington's disease (HD) is a neurodegenerative disorder caused by a CAG repeat expansion in the huntingtin gene. This expansion leads to toxic protein aggregation and neuronal death, but the exact mechanism remains unclear.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder.
- It is characterized by involuntary movements, cognitive decline, and mood disturbances.
- Pathologically, HD involves significant neuronal loss in the striatum and cerebral cortex.
Purpose of the Study:
- To investigate the genetic basis of Huntington's disease.
- To understand the molecular mechanisms underlying polyglutamine expansion diseases.
- To explore the formation and role of intracellular inclusions in neurodegeneration.
Main Methods:
- Analysis of brain tissue from HD patients and mouse models.
- Molecular and cellular studies focusing on protein aggregation.
- Genetic analysis of CAG repeat expansions in the huntingtin gene.
Main Results:
- The genetic defect in HD is an expanded CAG repeat in the huntingtin gene, encoding a polyglutamine stretch.
- The size of the CAG expansion correlates inversely with the age of HD onset.
- Abnormal intracellular inclusions, formed by aggregated mutant huntingtin protein, are observed in affected brains.
Conclusions:
- Polyglutamine expansion is a novel mechanism of neurodegeneration, implicated in HD and seven other inherited disorders.
- Mutant huntingtin protein gains a toxic function due to polyglutamine expansion.
- The precise mechanisms by which polyglutamine expansion causes selective neuronal dysfunction and death are still under investigation.
Abstract:
HD is an autosomal dominant neurodegenerative disorder characterized by involuntary movements, cognitive impairment progressing to dementia, and mood disturbances. The brains of patients show extensive neuronal loss in the striatum, and the cerebral cortex is also affected. The genetic defect causing HD is an expansion of a CAG repeat encoding a polyglutamine stretch in the target protein, named huntingtin. The age of onset of HD is inversely correlated with the size of the expansion. Polyglutamine expansion represents a novel cause of neurodegeneration, which has been shown to be responsible for seven other inherited disorders. The polyglutamine expansion confers a gain of toxic property to the mutated target proteins. Molecular and cellular studies of the brains of patients and of mice models of polyglutamine expansion diseases have led to the identification of abnormal intracellular inclusions representing aggregation of the mutated protein. However, the mechanism whereby such polyglutamine expansion leads to selective neuronal dysfunction and death is still puzzling.
More Related Videos
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Lysosomal Hydrolases
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Alzheimer Disease ll: Pathophysiology
Parkinson Disease ll: Pathophysiology
Huntington Disease l: Introduction

